GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales ...Middle East

Fortune - News
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
"We expect another year of profitable growth in 2025, and have further improved our long-term outlook," said CEO Walmsley. Read More

Hence then, the article about gsk reports fall in profit over zantac fallout but boosts 2031 revenue target to 40 billion due to boom in cancer drug sales was published today ( ) and is available on Fortune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News